Adam Young, MD
Interventional Pain Medicine · Chicago, ILNPI 1073769287
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Vertos Medical, Inc. at 41.2% of the total. Reporting peaked in 2023 at $14,603 and has fallen 79.2% since, to $3,045 in 2025. Among interventional pain medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $102.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$12K
- Abbott$5K
- Baxter Healthcare$4K
- Boston Scientific$2K
- Saluda Medical Americas, Inc.$1K
- Medtronic$752
- plus $4K from 19 others
What the payments were for
- Consulting fees$15,50053%
- Travel & lodging$1,0704%
- Food & beverage$12,53743%
- Education$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 12 | $12,006 |
| Abbott | 149 | $5,229 |
| Baxter Healthcare | 2 | $4,000 |
| Boston Scientific | 28 | $1,623 |
| Saluda Medical Americas, Inc. | 10 | $1,334 |
| Medtronic(2 entities) | 11 | $752 |
| Painteq LLC | 21 | $598 |
| Nevro Corp. | 8 | $571 |
| Biotronik NRO, Inc. | 9 | $510 |
| Nalu Medical, Inc. | 3 | $329 |
| Lenoss Medical Inc | 2 | $310 |
| Spinal Simplicity, LLC | 2 | $301 |
| Averitas Pharma Inc. | 4 | $259 |
| SPR Therapeutics, Inc | 8 | $241 |
| Curonix LLC | 3 | $184 |
| Stryker | 1 | $160 |
| Vertex | 2 | $136 |
| Pacira Pharmaceuticals Incorporated | 2 | $129 |
| Novo Nordisk | 1 | $116 |
| Integra Lifesciences Corporation | 1 | $91 |
| Vertiflex, Inc. | 1 | $89 |
| Relievant Medsystems, Inc. | 2 | $71 |
| Bard Access Systems, Inc. | 1 | $44 |
| Si-bone, Inc. | 1 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$12,079
- Fluid Systems - Infusion Systems$3,000
- Proclaim Family of SCS IPGs$1,059
- Evoke SCS$1,017
- Fluid Systems - Research Devel$1,000
- ETERNA$873
- PROCLAIM$825
- Intracept$738
- Proclaim IPG$602
- INTELLIS$399
- Senza$316
- OsteoPearl$310
- Prospera$299
- Nalu Neurostimulation System$282
- HA MINUTEMAN G3-R$281
- PATRIOT SI$281
- PAINTEQ$240
- CD HORIZON SPINAL SYSTEM$166
- Evoke$140
- Qutenza$133
How this compares
$29,140 in reported general payments places this provider in the 90th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 136 | $27,023 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 485 | $9,736 |
| Pregabalin | 420 | $9,313 |
| Gabapentin | 590 | $5,258 |
| Etodolac | 89 | $3,815 |
| Duloxetine Hcl | 211 | $3,569 |
| Lidocaine | 26 | $3,486 |
| Meloxicam | 249 | $1,332 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $1,217 |
| Tizanidine Hcl | 106 | $1,116 |
| Methylprednisolone | 166 | $951 |
| Tramadol Hcl | 172 | $940 |
| Diclofenac Sodium | 23 | $820 |
| Celecoxib | 65 | $729 |
| Morphine Sulfate | 30 | $585 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Chicago
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Salman SagarwalaChicago$26K
- Kenneth CandidoChicago$15K
- Sameer ShahChicago$10K
- James DiesfeldChicago$10K
- Xiaoyuam XieChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.